Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TSBX under $3
Nice biotech company. Looks like it wants to break out past $3.50. I think it has a lot more to run, JMO.
TSBX....here we go...monster bio
TSBX...MONSTER BIO BEAST IS READY TO BLOW UP
What was?
That was quick
New #JITC article: Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients https://t.co/jORw8004JP @JohnEMullinaxMD pic.twitter.com/a7RR2K5MrQ— Journal for ImmunoTherapy of Cancer (@jitcancer) October 6, 2023
New #JITC article: Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients https://t.co/jORw8004JP @JohnEMullinaxMD pic.twitter.com/a7RR2K5MrQ
Upcoming https://finance.yahoo.com/news/turnstone-biologics-present-preclinical-data-100000133.html
InvestorsHub community
Register for free to join our community of investors and share your ideas
You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow